MedTrace Logo

The Effect of Probiotics on Chronic Kidney Disease

NCT03228563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2022-07-21

No results posted yet for this study

Summary

Probiotics could attenuate renal function deterioration in CKD patients.

Conditions

Interventions

OTHER

Probioics

CKD Patients were supplemented with two capsules of probiotics containing 2.5\*10\^9 CFU Lactobacillus acidophilus (TYCA06), Bifidobacterium longum (BLI-02) and Bifidobacterium bifidum (VDD088) twice daily for 12 months.

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • I-kuan Wang · China Medical University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-23
Primary Completion
2021-08-19
Completion
2022-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03228563 on ClinicalTrials.gov